Skip to main content
Equibles
PLX logo

PLX · Protalix BioTherapeutics, Inc.

Track PLX — free

Use PLX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PLX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.30 +0.08 (+3.60%) At close · Aug 17
Market Cap
$178.87M
Shares
80.57M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
3,885,984 +0.2% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
68/100
Short interest 4.8% of shares — P73 Days to cover 7.5 — P82 Price vs VWAP 0.0% — P46 Short-volume trend +1.5% — P57 Short interest change +4.4% — P69 Worst FTD 0.04% of shares — P74

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 3,878,764 3,715,907 +162,857 7.46
    2026-07-15 3,715,907 3,558,923 +156,984 6.56
    2026-06-30 3,558,923 3,910,669 -351,746 4.18
    2026-06-15 3,910,669 3,935,161 -24,492 7.07
    2026-05-29 3,935,161 4,183,989 -248,828 4.93
    2026-05-15 4,183,989 5,055,741 -871,752 3.89
    2026-04-30 5,055,741 4,726,273 +329,468 9.74
    2026-04-15 4,726,273 4,702,042 +24,231 6.65
    2026-03-31 4,702,042 4,378,823 +323,219 3.91
    2026-03-13 4,378,823 4,174,736 +204,087 4.50
    2026-02-27 4,174,736 4,527,493 -352,757 2.77
    2026-02-13 4,527,493 4,116,458 +411,035 2.07
    2026-01-30 4,116,458 4,550,338 -433,880 4.60
    2026-01-15 4,550,338 4,211,881 +338,457 4.33
    2025-12-31 4,211,881 4,416,360 -204,479 6.77
    2025-12-15 4,416,360 4,156,781 +259,579 8.55
    2025-11-28 4,156,781 4,100,254 +56,527 8.18
    2025-11-14 4,100,254 4,156,466 -56,212 6.55
    2025-10-31 4,156,466 4,704,650 -548,184 3.62
    2025-10-15 4,704,650 4,152,594 +552,056 4.64
    2025-09-30 4,152,594 3,661,372 +491,222 6.08
    2025-09-15 3,661,372 3,596,098 +65,274 4.44
    2025-08-29 3,596,098 3,761,613 -165,515 6.13
    Showing 1–23 of 23 settlements
    Key facts CIK 1006281 CUSIP 74365A309 13F (30d) 98 filings 96 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)